Skip to content

Clinical trials

Completed Bronchiolitis Obliterans Syndrome trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Status: Completed Country / region: China Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20131
20171
20182
20192
20201
20212
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
BioNova Pharmaceuticals (Shanghai) LTD.1
Hoffmann-La Roche1
Peking University Third Hospital1
Pfizer1
Pharmacyclics LLC.1
Sanofi1
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine1
Shanghai Jiao Tong University School of Medicine1
Suzhou Municipal Hospital of Anhui Province1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome14
Graft vs Host Disease2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2
Lymphoma, Follicular2
Cardiovascular Diseases1
Cerebrovascular Disorders1
Dacryocystitis1
Headache1
Hepatitis B1
Joint Dislocations1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.